Navigation Links
Systemic Corticosteroid Therapy can be used for treating all types of Infectious Mononucleosis

Scott Thompson and colleagues from University of Rochester Medical Center, has found from review of records of patients treated with corticosteroids that Corticosteroids is the most effective and useful treatment// option for Infectious mononucleosis, including severe airway compromise mononucleosis. The results of the study have been published in Achieves of Otolaryngology – Head and Neck Surgery, JAMA Journal. The researcher’s analyzed data of patients treated for Infectious mononucleosis with corticosteroids from January 1998 to March 2003. The results of the study disapproved earlier controversies over the usage of systemic corticosteroids for infectious mononucleosis.

The study review showed that Corticosteroid therapy was used in 92 patients with infectious mononucleosis of the total 206 patients with infectious mononucleosis. These results show that there was an increase in doctors treating patients with infectious mononucleosis with corticosteroids. The patients were follow up for disease prognosis during regular physician visits, inpatient admissions and during consultations.

Dr. Scott Thompson said, “Despite consistent and uniform acceptance in the medical literature that SCT in the setting of IM [infectious mononucleosis] should be reserved for patients with impending airway obstruction, corticosteroids continue to be used on a much broader scale at this tertiary care institution and this observation suggests that clinicians see value in SCT for treatment of IM beyond the classically accepted reasons. Moreover, despite previous reports of possible adverse consequences of SCT in IM, our review failed to demonstrate any such trend.”

Source: News wie
'"/>




Page: 1

Related medicine news :

1. Systemic Pre-Surgical Treatment Can Prolong Survival Of Kidney Cancer Patients
2. New Treatment Offers Hope for Systemic Sclerosis
3. Corticosteroids Safe for Bones
4. Corticosteroids Safe for Bones
5. Inhaled Corticosteroids Found To Have No Significant Effect On COPD
6. The Effectiveness Of Inhaled Corticosteroids Studied
7. The Effectiveness Of Inhaled Corticosteroids Studied
8. Inhaled Corticosteroids Reduce Death in Patients with COPD
9. Short-Term Topical Corticosteroid May Offer Relief for Certain Type of Psoriasis
10. High-dose Inhaled Corticosteroid Use for COPD Could Cut Risk of Lung Cancer
11. High Dose Inhaled Corticosteroid Use for COPD Could Cut Risk of Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/21/2017)... ... April 21, 2017 , ... Brady (NYSE:BRC), a global leader ... and B-7569 vinyl label materials received certification for the BS5609 British ... to remain intact and legible, for use on chemical drums shipped by sea. ...
(Date:4/21/2017)... ... ... The adage “Show, don’t tell” applies perfectly to Green Builder Media’s Earth ... House demonstration project series. Manifesting the concept of right-sized living, the Flex House is ... affordably and abundantly without unduly taxing the resources of our beautiful planet. ...
(Date:4/21/2017)... ... 21, 2017 , ... The Hong Kong Polytechnic University (PolyU) launched today the ... education institutions in Hong Kong to support teaching, learning and research. It is also ... of facilities in Hong Kong. , With an area of 620 square metres ...
(Date:4/21/2017)... ... April 21, 2017 , ... Alive for Wellness is a group ... mental health struggles. The Alive team uses advanced behavioral sciences treatment modalities to ... with a mental health struggle is based on 10 modalities of treatment ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... ... Enterprise in the category of International Trade, the UK’s most prestigious award for ... trade, which represents 95% of total revenues and has grown by a total ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017  Vanderbilt University Medical ... patients in Nashville , Tennesse have ... Esophageal Sphincter Stimulation for GERD (LESS GERD) trial. The ... provide long-term reflux control by restoring normal function to ... 65 million people in the United States ...
(Date:4/19/2017)... , April 19, 2017  New research provides evidence that ... Parkinson,s, according to a study released today that will be ... Meeting in Boston , April 22 ... the treatment of Parkinson,s disease, the oral drug levodopa has ... and longevity. But as the disease progresses, the effects of ...
(Date:4/18/2017)... 2017 Cogentix Medical, Inc. (NASDAQ: CGNT), a ... Uro/Gyn and Gynecology markets with innovative and proprietary products, ... March 31, 2017 after the market close on Tuesday, ... host a conference call and webcast to discuss its ... 2017 at 4:30 p.m. Eastern Time (3:30 p.m. Central ...
Breaking Medicine Technology: